Clinical Trials Browser

Triple Negative Breast Neoplasms

Genital Neoplasms, Male

Stomach Neoplasms

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

Adenocarcinoma, Pancreatic Neoplasms

Leiomyosarcoma, Neoplasm Metastasis, Sarcoma

Pancreatic Neoplasms

Carcinoma, Non-Small-Cell Lung

Pancreatic Neoplasms

Resectable Pancreatic Cancer

Mesothelioma, Malignant

Metastatic Adenocarcinoma of the Pancreas

Parkinson Disease 4, Autosomal Dominant Lewy Body, Bile Duct Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

Advanced Pancreatic Carcinoma

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Pancreatic Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

Neoplasms, Pancreatic Neoplasms

Biliary Tract Neoplasms

Lymphoma, Large B-Cell, Diffuse

Nasopharyngeal Carcinoma

Adenocarcinoma, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

Osteosarcoma

Recurrence, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma

Fibrosis, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral

Parkinson Disease 4, Autosomal Dominant Lewy Body, Bile Duct Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

Urinary Bladder Neoplasms

Gastrointestinal Neoplasms

Urinary Bladder Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Triple Negative Breast Neoplasms

Adenoviridae Infections, Neoplasms, Pancreatic Neoplasms

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Uterine Cervical Neoplasms

Pancreatic Intraductal Neoplasms

Carcinoma, Non-Small-Cell Lung

Colorectal Neoplasms, Cholangiocarcinoma

Advanced Cancer

Parkinson Disease 4, Autosomal Dominant Lewy Body, Urinary Bladder Neoplasms

Pancreatic Neoplasms

Non-Small-Cell Lung

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Pancreas Adenocarcinoma

Parkinson Disease 4, Autosomal Dominant Lewy Body, Hodgkin Disease

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Gallbladder Neoplasms, Cholangiocarcinoma

Carcinoma, Non-Small-Cell Lung

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Pancreatic Neoplasms

Lymphoma, Lymphoma, Large B-Cell, Diffuse

Clinical Trials

TRIFOUR

Phase 2 Study of Association Gemcitabine-Cisplatin to Treat Penis Epidermoid Carcinoma

A Phase Ib/II Clinical Study Evaluating HMPL-453 Tartrate as Monotherapy and in Combination With Chemotherapy or Toripalimab in Advanced Solid Tumors

Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients

NABPLAGEMD

TARSARC

EF-39 PANOVA-4: Study of Tumor Treating Fields Concomitant With Atezolizumab, Gemcitabine and Nab-Paclitaxel as First-LineTreatment for Metastatic Pancreatic Ductal Adenocarcinoma

SLAT

Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic Cancer

Pre-operative Treatment for Patients With Untreated Pancreatic Cancer

INFINITE

NAPOLI 3

KEYNOTE-966

HCW9218 for Advanced Pancreatic Cancer

Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors

Carbon Ion Radiation Therapy for Locally Advanced Pancreatic Cancer

Phase II Randomized Trial of SLOG vs GC in Locally Advanced or Metastatic Biliary Tract Cancer

INCA

TQB2618 Injection Combined With Penpulimab Injection in the Treatment of Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma

Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer

A Study of Azenosertib (ZN-c3) in Combination With Gemcitabine in Subjects With Osteosarcoma

Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma

A Phase Ib/II Clinical Trial of LBL-007 Combined With Tislelizumab in the Treatment of Malignant Tumors

A Study to Assess an ATX Inhibitor (IOA-289) in Patients With Metastatic Pancreatic Cancer

Romidepsin, Gemcitabine, Dexamethasone and Cisplatin in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma

KEYNOTE-966

Phase 2 Study of Pembrolizumab in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy

BREGO

Image-Guided Radiation Therapy for Bladder-Cancer Patients Undergoing Radiotherapy and Concurrent Gemcitabine Chemotherapy

KEYLYNK-009

LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer

A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)

innovaTV 301

Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery

Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)

GEMMK

A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma

RP-6306 in Patients With Advanced Cancer

KEYNOTE-B15

Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer

A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)

Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC)

Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)

MK-4280A-008

A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)

Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers

CheckMate 816

Neoadjuvant Toripalimab in Combination With Gemcitabine Therapy in Cisplatin Ineligible Local Advanved Bladder Cancer

Pancreas

POLARGO